Qualigen Therapeutics, Inc.

QLGN · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$1,175$402$3,166$17,538
Short-Term Investments$0$0$0$0
Receivables$2,011$0$539$822
Inventory$0$0$1,586$1,056
Other Curr. Assets$1,499$765$5,530$1,380
Total Curr. Assets$4,685$1,167$10,821$20,796
Property Plant & Equip (Net)$0$0$26$1,850
Goodwill$0$0$626$0
Intangibles$0$0$5,846$171
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$2$866$1,765$18
Total NC Assets$2$866$8,263$2,039
Other Assets$0$0$0-$0
Total Assets$4,687$2,033$19,083$22,836
Liabilities
Payables$1,568$2,223$620$886
Short-Term Debt$0$1,299$455$134
Tax Payable$0$0$32$18
Deferred Revenue$0$0$116$135
Other Curr. Liab.$439$615$7,385$3,462
Total Curr. Liab.$2,007$4,137$8,608$4,635
LT Debt$0$0$1,302$1,543
Deferred Rev, NC$0$0$49$93
Deferred Tax Liab, NC$0$0$358$0
Other NC Liab.$0$0$0$0
Total NC Liab.$0$0$1,709$1,635
Other Liabilities$0$0$0$0
Cap. Leases$0$0$1,697$1,677
Total Liabilities$2,007$4,137$10,317$6,271
Equity
Pref Stock$5,716$0$0$0
Common Stock$65$43$42$35
Retained Earnings-$123,062-$116,802-$103,385-$84,745
AOCI$0$0$51$0
Other Equity$119,959$114,656$110,528$101,274
Total Equity$2,679-$2,104$7,236$16,565
Supplemental Information
Minority Interest$0$0$1,531$0
Total Liab. & Tot. Equity$4,687$2,033$19,083$22,836
Net Debt-$1,175$897-$1,409-$15,862